Study of serum fibrinogen level in type 2 diabetes mellitus
Author(s): Dr. KS Abishek, Dr. Saritha K Narayanan and Dr. M Ramakrishna Rao
Abstract: Objective: To estimate the level of fibrinogen in patients with type 2 diabetes mellitus.
Methods: We conducted a hospital based study of 100 random patients, divided into 4 groups, 25 in each group and compared serum fibrinogen between the group during the study period from November 2019 to April 2021.
The patients will be sub classified into four groups:
•Patients with type 2 diabetes mellitus without complications (Group – A).
•Patients with type 2 diabetes mellitus with microvascular complications (Group – B).
•Patients with type 2 diabetes mellitus with macrovascular complications (Group – C).
•Patients with type2 diabetes mellitus with both microvascular and macrovascular complications (Group – D).
Results: The difference between serum fibrinogen levels among 4 groups were statistically significant (p< 0.001)
Conclusion: Fibrinogen could be potential marker for prediction and prevention of microvascular and macrovascular complication.
DOI: 10.22271/27069567.2022.v4.i1a.310Pages: 01-04 | Views: 962 | Downloads: 492Download Full Article: Click HereHow to cite this article:
Dr. KS Abishek, Dr. Saritha K Narayanan, Dr. M Ramakrishna Rao.
Study of serum fibrinogen level in type 2 diabetes mellitus. Int J Adv Res Med 2022;4(1):01-04. DOI:
10.22271/27069567.2022.v4.i1a.310
